Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Recent
Upcoming
Share :

Myeloma Knowledge Exchange 2021 (MyKE Myeloma)

Videos
Anti-CD38 immunotherapy treatment for multiple myeloma
Prof Xavier Leleu - CHU de Poitiers, Poitiers, France
Anti-CD38 immunotherapy treatment for multiple myeloma ( Prof Xavier Leleu - CHU de Poitiers, Poitiers, France )
22 Nov 2021
Triple class refractory multiple myeloma
Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix...
Triple class refractory multiple myeloma ( Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix, USA )
10 Nov 2021
Managing high-risk/MRD positive and standard-risk/MRD myeloma
Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy
Managing high-risk/MRD positive and standard-risk/MRD myeloma ( Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy )
29 Oct 2021
Minimum residual disease techniques in myeloma
Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy
Minimum residual disease techniques in myeloma ( Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy )
29 Oct 2021
Identifying and treating high-risk/MRD positive newly diagnosed multiple myeloma
Prof Wee Joo Chng - National University Cancer Institute, Singapore
Identifying and treating high-risk/MRD positive newly diagnosed multiple myeloma ( Prof Wee Joo Chng - National University Cancer Institute, Singapore )
29 Oct 2021
High-risk SMM imaging and NDMM treatment
Dr Elena Zamagni - University of Bologna, Bologna, Italy
High-risk SMM imaging and NDMM treatment ( Dr Elena Zamagni - University of Bologna, Bologna, Italy )
28 Oct 2021
Rescue after daratumumab failure
Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix...
Rescue after daratumumab failure ( Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix, USA )
26 Oct 2021
MRD-driven strategies and novel immunotherapies for multiple myeloma
Prof Simon Harrison - Peter MacCallum Cancer Centre, Melbourne, Australia
MRD-driven strategies and novel immunotherapies for multiple myeloma ( Prof Simon Harrison - Peter MacCallum Cancer Centre, Melbourne, Australia )
25 Oct 2021
How to approach pain management in myeloma patients
Prof Wolfgang Grisold - Medical University of Vienna, Vienna, Austria
How to approach pain management in myeloma patients ( Prof Wolfgang Grisold - Medical University of Vienna, Vienna, Austria )
20 Oct 2021
Refractoriness and retreatment in the era of lenalidomide and mABs in the...
Dr Fredrik Schjesvold - Oslo Myeloma Center, Oslo, Norway
Refractoriness and retreatment in the era of lenalidomide and mABs in the frontline myeloma setting ( Dr Fredrik Schjesvold - Oslo Myeloma Center, Oslo, Norway )
18 Oct 2021

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation